Hypofractionated External-beam RadiOtherapy for Intact Cervical Cancer (HEROICC-Trial): A Feasibility Study
Condition: Cervical Cancer Interventions: Radiation: External beam radiotherapy (EBRT) + High-dose rate (HDR) Brachytherapy Experimental; Radiation: External beam radiotherapy (EBRT) + High-dose rate (HDR) Brachytherapy Standard of Care; Drug: Concurrent Chemotherapy Sponsors: Lawson Health Research Institute; Academic Medical Organization of Southwestern Ontario Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 12, 2020 Category: Research Source Type: clinical trials
Uveal Melanoma and Brachytheraphy: Long-term Outcomes.
Conditions: 106 Ruthenium Plaque Brachytherapy; Uveal Melanoma Intervention: Radiation: 106 Ruthenium plaque brachytherapy Sponsor: Federico II University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 8, 2020 Category: Research Source Type: clinical trials
Cs-131 brachytherapy for patients with recurrent glioblastoma combined with bevacizumab avoids radiation necrosis while maintaining local control
(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)
Source: Clinical Trials And Noteworthy Treatments For Brain Tumors - September 18, 2020 Category: Cancer & Oncology Source Type: clinical trials
Neoadjuvant Interstitial Brachytherapy Using Diffusing Alpha Emitters Radiation Therapy in Men With Prostate Cancer
Condition: Prostate Adenocarcinoma Intervention: Device: Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT) Sponsor: Alpha Tau Medical LTD. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 10, 2020 Category: Research Source Type: clinical trials
Brachytherapy Innovations in Gynecologic Cancer
Condition: Gynecologic Cancer Intervention: Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 28, 2020 Category: Research Source Type: clinical trials
HDR Brachytherapy Plus Stereotactic Ablative Prostate Radiotherapy for Patients With Intermediate and High-risk Prostate Cancer
Condition: Prostatic Neoplasm Intervention: Radiation: Real time High-Dose-Rate prostate brachytherapy in combination with stereotactic prostate radiotherapy Sponsor: David Büchser Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 24, 2020 Category: Research Source Type: clinical trials
